Institutional investors hold a majority ownership of AMGN through the 82.86% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NATIONWIDE FUND ADVISORS Bought 262.1 Thousand shares of Amgen
STATE STREET GLOBAL ADVISORS LTD... Bought 259.0 Thousand shares of Amgen
BOSTON ADVISORS LLC Bought 228.2 Thousand shares of Amgen